Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy - Concepedia

Concepedia

Publication | Open Access

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy

DOI Full Paper Access

74

Citations

30

References

2020

Year

Shunying Li, Hongna Lai, Jieqiong Liu, Yujie Liu, Liang Jin, Yudong Li, Fengtao Liu, Yuhua Gong, Yanfang Guan, Xin Yi,

JCO Precision Oncology

Abstract

Our study demonstrated that ctDNA can be used to predict tumor response to NAC and prognosis in early breast cancer, providing information to tailor an individual's therapeutic regimen.

References

	Year	Citations

Page 1